Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
While the fourth deadliest Ebola outbreak in the Democratic Republic of the Congo continues — and still has the potential to explode domestically and beyond its border — there may be signs of a slowdown.
What's new: The DRC Ministry of Health announced Thursday that 9 people have been cured. As of Aug. 22, the total number of suspected cases topped 100, but only 13 people were being investigated. However, experts warn that it is too early to say if the outbreak has reached its peak.
"We're not out of the woods yet. ... You'll know when an outbreak has peaked when any new cases can be traced back to someone you already knew was infected."— Julie E. Fischer, director, Elizabeth R. Griffin Program, Georgetown University Medical Center
"We'll know in a couple of weeks if the ring vaccination, positive communication [and experimental therapies] worked," Fischer tells Axios.
The problem with this particular outbreak, Fischer says, is the difficulty health care workers have in reaching possibly infected people in conflict areas. And, this is compounded by DRC's wide range of languages and cultural differences, leading to demand for multilingual medical workers who can negotiate the different local customs.
- But, despite these obstacles, health officials from DRC, the World Health Organization and numerous other organizations have done a "great job" of hunting down possible infections, Fischer says. She points to WHO's statement that officials believe they have been able to trace 95% of infections.
What's happening now, according to releases from DRC's Ministry of Health Aug. 21-23:
- DRC administered 2,613 experimental rVSV-ZEBOV vaccinations to those believed to have come into contact with infected persons or who are at the highest risk.
- Beginning Aug. 11, health officials started distributing experimental treatment mAb114 to 10 patients, with positive results so far.
- On Aug. 21, another experimental treatment, Remdesivir, was given to a patient in Beni's Ebola treatment center (CTE) and that person is "doing well," the ministry said.
- DRC's Ethics Committee approved three other experimental treatments — Zmapp, favipiravir, and Regn3450-3471-3479, which will be distributed to the CTEs.
Editor's note: This piece was updated with the latest information from DRC's Ministry of Health, updating all the numbers and adding the 9 people cured.